Starting point for benchmarking outcomes and reporting of pituitary adenoma surgery within the European Reference Network on Rare Endocrine Conditions (Endo-ERN): results from a meta-analysis and survey study

Zamanipoor Najafabadi, A. H. et al. (2023) Starting point for benchmarking outcomes and reporting of pituitary adenoma surgery within the European Reference Network on Rare Endocrine Conditions (Endo-ERN): results from a meta-analysis and survey study. Endocrine Connections, 12(1), e220349. (doi: 10.1530/EC-22-0349) (PMID:36327151) (PMCID:PMC9782450)

Abstract

The European Reference Network on Rare Endocrine Conditions (Endo-ERN) aims to organize high-quality healthcare throughout Europe, including care for pituitary adenoma patients. As surgery is the mainstay of treatment, we aimed to describe the current surgical practice and published surgical outcomes of pituitary adenoma within Endo-ERN. Systematic review and meta-analysis of studies reporting surgical outcomes of pituitary adenoma patients within Endo-ERN MTG6 Pituitary Reference Centers between 2010 and 2019. A survey was completed by Reference Centers on their current surgical practice. Eighteen out of 43 (42%) Reference Centers located in seven of the 20 (35%) MTG6 represented countries published 48 articles. Remission rates were 50% (95%CI: 42-59) for patients with acromegaly, 68% (95%CI: 60-75) for Cushing's disease, and 53% (95%CI: 39-66%) for prolactinoma. Gross total resection was achieved in 49% (95%CI: 37-61%) of patients, visual improvement in 78% (95%CI: 68-87). Mortality, hemorrhage, and carotid injury occurred in less than 1% of patients. New onset hypopituitarism occurred in 16% (95%CI: 11-23), transient diabetes insipidus in 12% (95%CI: 6-21), permanent diabetes insipidus in 4% (95%CI: 3-6), SIADH in 9% (95%CI: 5-14), severe epistaxis in 2% (95%CI: 0-4), and CSF leak in 4% (95%CI: 2-6). Thirty-five (81%) centers completed the survey: 54% operate endoscopically, 57% together with an ENT-surgeon. The results of this study could be used as a first benchmark for outcomes of pituitary adenoma surgery within Endo-ERN. However, the heterogeneity between studies in the reporting of outcomes hampers comparability, and warrants outcome collection through registries.

• Item Type: Articles
• Additional Information: This publication has been supported by Endo-ERN, which is co-funded by the European Union’s third Health Programme (CHAFEA Framework Partnership Agreement No 739527).
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: Ahmed, Professor Syed Faisal
• Authors: Zamanipoor Najafabadi, A. H., van der Meulen, M., Priego Zurita, A. L., Ahmed, S. F., van Furth, W. R., Charmandari, E., Hiort, O., Pereira, A. M., Dattani, M., Vitali, D., de Graaf, J. P., and Biermasz, N. R.
• College/School: College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
• Journal Name: Endocrine Connections
• Publisher: Bio Scientifica
• ISSN: 2049-3614
• ISSN (Online): 2049-3614
• Published Online: 13 December 2022
• Copyright Holders: Copyright © 2022 The Authors
• First Published: First published in Endocrine Connections 12(1):e220349
• Publisher Policy: Reproduced under a Creative Commons License